Locations:
Search IconSearch
January 19, 2016/Cancer/News & Insight

Why Value-Based Cancer Care Can’t Wait

Reducing time to treatment is good for patients and the healthcare system

time_60x450

Physicians and patients don’t always agree on which outcomes are most important in cancer care. An example is the amount of time it takes to initiate treatment after a solid tumor diagnosis. Shortening the time-to-treat interval wouldn’t impact the medical outcome in the view of most oncologists, but to an anxious cancer patient, any wait is too long. And with medical value (and reimbursement) increasingly tied to delivery of patient-centered, timely care, the oncology community must embrace initiatives to quantify and improve these issues.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

bolwell0_150x180
Khorana_150x180

In this viewpoint article in the Journal of the National Comprehensive Cancer Network, Cleveland Clinic Taussig Cancer Institute Chairman Brian J. Bolwell, MD, and Vice-Chair for Clinical Services and Strategy Alok A. Khorana, MD, make the case for value-based, patient-focused cancer care and describe Cleveland Clinic Cancer Center’s initial efforts to shorten time to treatment using integrated practice techniques.

Photo Credit: ©Russell Lee

Advertisement

Related Articles

adverse events from immune checkpoint inhibitors
December 21, 2023/Cancer/News & Insight
Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

23-CNR-4274330-CQD-Hero-650×450
October 18, 2023/Cancer/News & Insight
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/News & Insight
Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight
Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

23-CNR-4185077-CQD-Hero-650×450
August 31, 2023/Cancer/News & Insight
CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

outreach to underserved communities
June 2, 2023/Cancer/News & Insight
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials

Long-term relationship building and engagement key to gaining community trust

Ad